A. , Le plan pour financer l'accès territorial de soins (11 avril 2018)

, Consulté le 02 octobre, 2018.

C. Baudouin, P. J. Pisella, C. Baudouin, and T. Hoang-xuan, De nouveaux schémas pour mieux comprendre les maladies de la surface oculaire

, Société Française d'ophtalmologie, rapport 2015 : Surface oculaire. Issy les Moulineaux, vol.2015, pp.159-163, 2018.

Z. Al-saedi, A. Zimmerman, R. D. Bachu, S. Dey, Z. Shah et al., Dry eye disease: present challenges in the management and future trends, Curr Pharm Des, vol.22, pp.4470-90, 2016.

, The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye Workshop, Ocul Surf, vol.5, pp.93-107, 2007.

M. J. Doughty, D. Fonn, D. Richter, T. Simpson, B. Caffery et al., A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada, Optom Vis Sci, vol.74, pp.624-655, 1997.

S. E. Moss, R. Klein, and B. E. Klein, Prevalence of and risk factors for dry eye syndrome, Arch Ophthalmol, vol.118, pp.1264-1272, 2000.

D. A. Schaumberg, D. A. Sullivan, J. E. Buring, and M. R. Dana, Prevalence of dry eye syndrome among US women, Am J Ophthalmol, vol.136, pp.318-344, 2003.

F. Fajnkuchen, V. Sarda, G. Chaine, . Ophtalmologie, and . Paris, , 2008.

C. A. Mccarty, A. K. Bansal, P. M. Livingston, Y. L. Stanislavsky, and H. R. Taylor, The epidemiology of dry eye in Melbourne, Australia. Ophthalmology, vol.105, pp.1114-1123, 1998.

A. J. Lee, J. Lee, S. M. Saw, G. Gazzard, D. Koh et al., Prevalence and risk factors associated with dry eye symptoms : a population based study in Indonesia

, Br J Ophthalmol, vol.86, pp.1347-51, 2002.

M. Uchino, D. A. Schaumberg, M. Dogru, Y. Uchino, K. Fukagawa et al., Prevalence of dry eye disease among Japanese visual display terminal users, Ophthalmology, vol.115, pp.1982-1990, 2008.

M. Uchino, Y. Nishiwaki, T. Michikawa, K. Shirakawa, E. Kuwahara et al., Prevalence and risk factors of dry eye isease in Japan : Koumi study, Ophthalmology, vol.118, pp.2361-2368, 2011.

M. Uchino, M. Dogru, Y. Uchino, K. Fukagawa, S. Shimmura et al.,

, Japan Ministry of Health study on prevalence of dry eye disease among Japanese high school students, Am J Ophthalmol, vol.146, pp.925-934, 2008.

M. Uchino, N. Yokoi, Y. Uchino, M. Dogru, M. Kawashima et al., Prevalence of dry eye disease and its risk factors in visual display terminal users : the Osaka study, Am J Ophthalmol, vol.156, pp.759-66, 2013.

A. J. Paulsen, K. J. Cruickshanks, M. E. Fischer, G. H. Huang, B. E. Klein et al., Dry eye in the Beaver Dam Offspring Study : prevalence, risk factors, and healthrelated quality of life, Am J Ophthalmol, vol.157, pp.799-806, 2014.

B. D. Sullivan, J. E. Evans, M. R. Dana, and D. A. Sullivan, Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions, Arch Ophthalmol, vol.124, pp.1286-92, 2006.

D. S. Ismailova, A. A. Fedorov, and Y. O. Grusha, Ocular surface changes in thyroid eye disease, Orbit, vol.32, pp.87-90, 2013.

I. N. Kaiserman, N. Kaiserman, S. Nakar, and S. Vinker, Dry eye in diabetic patients, Am J Ophthalmol, vol.139, pp.498-503, 2005.

C. L. Chronister, Review of external ocular disease associated with aids and HIV infection, Optom Vis Sci, vol.73, pp.225-255, 1996.

H. Merle, D. Smadja, L. Hoang, P. Bera, O. Cabre et al., Ocular manifestations in patients with HTLV-I associated infection-a clinical study of 93 cases, Jpn J Ophthalmol, vol.40, pp.260-70, 1996.

C. Baudouin, P. Aragona, E. M. Messmer, A. Tomlinson, M. Calonge et al., Role of hyperosmolarity in the pathogenesis and management of dry eye disease : proceedings of the OCEAN group meeting, Ocul Surf, vol.4, pp.246-58, 2013.

J. P. Mcculley, J. D. Aronowicz, E. Uchiyama, W. E. Shine, and I. A. Butovich, Correlations in a change in aqueous tear evaporation with a change in relative humidity and the impact, Am J Ophthalmol, vol.141, pp.758-60, 2006.

J. M. Cermak, A. S. Papas, R. M. Sullivan, M. R. Dana, and D. A. Sullivan, Nutrient intake in women with primary and secondary Sjogren's syndrome, Eur J Clin Nutr, vol.57, pp.328-362, 2003.

B. Miljanovi?, K. A. Trivedi, M. R. Dana, J. P. Gilbard, J. E. Buring et al., Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women, Am J Clin Nutr, vol.82, pp.887-93, 2005.

A. Sommer, Vitamin A deficiency and the global response, Forum Nutr, vol.56, pp.33-38, 2003.

C. Baudouin, A. Labbé, H. Liang, A. Pauly, and F. Brignole-baudouin, Preservatives in eyedrops: the good, the bad and the ugly, Prog Retin Eye Res, vol.29, pp.312-346, 2010.

Q. Pan, A. Angelina, A. Zambrano, M. Marrone, W. J. Stark et al.,

, Methodologies to diagnose and monitor dry eye disease: report of the diagnostic methodology subcommittee of the International Dry Eye WorkShop, Cochrane Database Syst Rev, vol.5, issue.8, pp.108-52, 2007.

M. El-hamdaoui, A. Denoyer, C. Baudouin, P. J. L'oeil-sec-:-l'enquête-diagnostique-;-pisella, C. Baudouin et al., Société Française d'ophtalmologie, rapport 2015 : Surface oculaire, vol.2015, pp.201-212

C. Baudouin, A. Rousseau, T. Hassani, R. Labetoulle, M. Pisella et al., Société Française d'ophtalmologie, rapport 2015 : Surface oculaire, vol.2015, pp.631-642

C. W. Roberts, P. E. Carniglia, and B. G. Brazzo, Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye, Cornea, vol.26, pp.805-814, 2007.

R. Bourkiza and V. Lee, A review of the complications of lacrimal occlusion with punctal and canalicular plugs, Orbit, vol.31, pp.86-93, 2012.

M. Ono, E. Takamura, K. Shinozaki, T. Tsumura, T. Hamano et al.,

, Therapeutic effect of cevimeline on dry eye in patients with Sjogren's syndrome: a randomized, double-blind clinical study, Am J Ophthalmol, vol.138, pp.6-17, 2004.

A. S. Papas, Y. S. Sherrer, M. Charney, H. E. Golden, T. A. Medsger et al., Successful treatment of dry mouth and dry eye symptoms in Sjogren's syndrome patients with oral pilocarpine : a randomized, placebo-controlled, dose-adjustment study, J Clin Rheumatol, vol.10, pp.169-77, 2004.

C. Schultz, Safety and efficacy of cyclosporine in the treatment of chronic dry eye, Ophthalmol Eye Dis, vol.6, pp.37-42, 2014.

H. Datta, K. Sarkar, and P. R. Chatterjee, Amniotic membrane transplantation in ocular surface disorders, Journal of the Indian Medical Association, vol.12, pp.726-735, 2004.

M. Muraine and J. Gueudry, Greffes de membranes amniotiques : indications et techniques, Pisella PJ, Baudouin C, Hoang-Xuan T. Société Française d'ophtalmologie, rapport 2015 : Surface oculaire. Issy les Moulineaux, pp.561-570, 2015.

F. Brignole-baudouin, J. M. Warnet, D. Barritault, and C. Baudoin, RGTA-based matrix therapy in severe experimental corneal lesions: safety and efficacy studies, J Fr Ophtalmol, vol.36, pp.740-747, 2013.

E. Anitua, M. De-la-fuente, F. Muruzabal, A. Riestra, J. Merayo-lloves et al., PRGF eye drops stimulates scarless regeneration compared to autologous serum, Exp Eye Res, vol.135, pp.118-144, 2015.

E. Anitua, F. Muruzabal, A. Tayebba, A. Riestra, V. Perez et al.,

, Autologous serum and plasma rich in growth factors in ophthalmology preclinical and clinical studies, Acta Ophthalmol, vol.93, pp.605-619, 2015.

E. Anitua, F. Muruzabal, A. Pino, J. Merayo-lloves, and G. Orive, Biological Stability of Plasma Rich in Growth Factors Eye Drops After Storage of 3 Months, Cornea, vol.32, pp.1380-1386, 2013.

C. Baudouin, C. Creuzot-garcher, T. Hoang-xuan, and M. C. Rigeade,

Y. and B. A. , Severe impairment of health-related quality of life in patients suffering from ocular surface diseases, J Fr Ophtalmol, vol.31, pp.369-78, 2008.

B. Miljanovic, R. Dana, D. A. Sullivan, and D. A. Schaumberg, Impact of dry eye syndrome on vision-related quality of life, Am J Ophthalmol, vol.143, pp.409-424, 2007.

P. Mertzanis, L. Abetz, K. Rajagopalan, D. Espindle, R. Chalmers et al., The relative burden of dry eye in patients' lives: comparisons to a US normative sample, Invest Ophthalmol Vis Sci, vol.46, pp.46-50, 2005.

H. A. Stevenson, M. E. Jones, J. L. Rostron, L. P. Longman, and E. A. Field, UK patients with primary Sjogren's syndrome are at increased risk from clinical depression

, Gerodontology, vol.21, pp.141-146, 2004.

G. G. Quinto, M. Campos, and A. Behrens, Autologous serum for ocular surface diseases

, Arq Bras Oftalmol, vol.71, issue.6, pp.47-54, 2008.

A. Muselier-mathieu and C. Creuzot-garcher, Traitements particuliers : Sérum autologue et thérapies matricielles

, Société Française d'ophtalmologie, rapport 2015 : Surface oculaire. Issy les Moulineaux, vol.2015, pp.571-584, 2018.

J. C. Bradley, J. Simoni, R. H. Bradley, D. L. Mccartney, and S. M. Brown, Time and temperature-dependent stability of growth factor peptides in human autologous serum eye drops, Cornea, vol.28, pp.200-205, 2009.

S. Bonini, P. Rama, D. Olzi, and A. Lambiase, Neutrophic keratitis, Eye (Lond), vol.17, pp.989-95, 2003.

R. I. Fox, R. Chan, J. B. Michelson, J. B. Belmont, and P. E. Michelson, Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca, Arthritis Rheum, vol.27, pp.459-61, 1984.

K. Tsubota, E. Goto, H. Fujita, M. Ono, H. Inoue et al., Treatment of dry eye by autologous serum application in Sjogren's syndrome, Br J Ophthalmol, vol.83, pp.390-395, 1999.

K. Tsubota, E. Goto, S. Shimmura, and J. Shimazaki, Treatment of persistent corneal epithelial defect by autologous serum application, Ophthalmology, vol.106, pp.1984-1993, 1999.

M. Beylerian, M. Lazaro, J. Magalon, J. Veran, A. Darque et al., Autologous serum tears: Long-term treatment in dry eye syndrome, J Fr Ophtalmol, vol.41, pp.246-254, 2018.

A. A. Azari and C. J. Rapuano, Autologous serum eye drops for the treatment of ocular surface disease, Eye Contact Lens, vol.41, pp.133-173, 2015.

J. Hwang, S. Chung, S. Jeon, S. K. Kwok, S. H. Park et al., Comparison of clinical efficacies of autologous serum eye drops in patients with primary and secondary Sjögren syndrome, Cornea, vol.33, pp.663-670, 2014.

E. M. Rocha, F. S. Pelegrino, C. S. De-paiva, A. C. Vigorito, D. Souza et al., GVHD dry eyes treated with autologous serum tears, Bone Marrow Transplant, vol.25, pp.1101-1104, 2000.

A. A. Azari, R. Karadag, M. R. Kanavi, S. Nehls, N. Barney et al., Safety and efficacy of autologous serum eye drop for treatment of dry eyes in graft-versushost disease, Cutan Ocul Toxicol, vol.36, pp.152-156, 2017.

M. Hussain, R. M. Shtein, A. Sugar, H. K. Soong, M. A. Woodward et al.,

, Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease, Cornea, vol.33, pp.1245-51, 2014.

A. M. Guadilla, P. Balado, A. Baeza, and M. Merino, Effectiveness of topical autologous serum treatment in neurotrophic keratopathy, Arch Soc Esp Oftalmol, vol.88, pp.302-308, 2013.

B. H. Jeng, Use of autologous serum in the treatment of ocular surface disorders, Arch Ophthalmol, vol.129, pp.1610-1612, 2011.

B. H. Jeng and W. J. Dupps, Autologous serum 50 % eyedrops in the treatment of persistent corneal epithelial defects, Cornea, vol.28, pp.1104-1112, 2009.

, Ministère des solidarités et de la santé

, Règles de facturation des soins dispensés dans les établissements de santé (rétrocession des médicaments

J. S. López-garcía, I. García-lozano, L. Rivas, N. Ramírez, M. T. Méndez et al., Stability of Growth Factors in Autologous Serum Eyedrops After Long-Term Storage, Curr Eye Res, vol.41, pp.292-300, 2016.

K. R. Fischer, A. Opitz, M. Böeck, and G. Geerling, Stability of serum eye drops after storage of 6 months, Cornea, vol.31, pp.1313-1321, 2012.

F. Blasetti, D. Usai, S. Sotgia, C. Carru, S. Zanetti et al., A protocol for microbiologically safe preparation, storage, and use of autologous serum eyedrops in low-income countries, J Infect Dev Ctries, vol.9, pp.55-64, 2015.